SCHEMBL5162563

SCHEMBL5162563

Cc1c(C(=O)O)c(O)c2ccccc2c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 3/20 0.50
▸ LDHA P00338 3/20 0.46
▸ LDHB P07195 3/20 0.46
▸ TSHR P16473 2/20 0.46
▸ HPGD P15428 3/20 0.46
▸ HSD17B10 Q99714 3/20 0.46
▸ CYP2C9 P11712 2/20 0.46
▸ THRB P10828 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ ATIC P31939 1/20 0.46
▸ KDM4E B2RXH2 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ GLA P06280 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ DHODH Q02127 2/20 0.44
▸ MAPT P10636 1/20 0.43
▸ PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5160775 0.90 PDE10A (0.49) PDE10ALDHALDHBTSHRHPGD
SCHEMBL8074031 0.86 LDHA (0.51) PDE10ALDHALDHBTSHRHPGD
SCHEMBL30706629 0.86 LDHA (0.49) PDE10ALDHALDHBTSHRHPGD
SCHEMBL19203141 0.86 LDHA (0.49) PDE10ALDHALDHBTSHRHPGD
SCHEMBL31520079 0.86 LDHA (0.51) PDE10ALDHALDHBTSHRHPGD
SCHEMBL6171244 0.86 PDE10A (0.49) PDE10ALDHALDHBTSHRHPGD
SCHEMBL2791364 0.85 KMT2A (0.46) PDE10ALDHALDHBTSHRHPGD
SCHEMBL2790721 0.85 PDE10A (0.45) PDE10ALDHALDHBTSHRHPGD
SCHEMBL4415520 0.84 HSD17B10 (0.54) PDE10ALDHATSHRHPGDHSD17B10
SCHEMBL31414101 0.84 HSD17B10 (0.54) PDE10ALDHATSHRHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106176709-B Pharmaceutical composition for treating tuberculosis and preparation method thereof 顺天乡大学校产学协力团 2020-02-07 — — CN disclosed
EP-2892343-A1 USE OF SUBSTITUTED 2,3-DIHYDRO-1-BENZOFURAN-4-CARBOXYLIC ACIDS OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS Bayer CropScience AG (DE) 2015-07-15 — — EP disclosed
WO-2014037349-A1 USE OF SUBSTITUTED 2,3-DIHYDRO-1-BENZOFURAN-4-CARBOXYLIC ACIDS OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2014-03-13 — — WO disclosed
EP-1000025-B1 SUBSTITUTED NAPHTHOPYRANS TRANSITIONS OPTICAL INC (US) 2007-02-21 — — EP disclosed
EP-1112263-B1 POLYMERIZABLE POLYALKOXYLATED NAPHTHOPYRANS TRANSITIONS OPTICAL INC (US) 2005-06-08 — — EP disclosed
EP-0835870-B1 Photochromic substituted naphthopyrans PPG IND OHIO INC (US) 2004-03-03 — — EP disclosed
EP-1112264-B1 POLYALKOXYLATED NAPHTHOPYRANS TRANSITIONS OPTICAL INC (US) 2002-11-27 — — EP disclosed
US-20020173667-A1 NOVEL AROMATIC SUBSTITUTED NAPHTHOPYRANS TRANSITIONS OPTICAL LIMITED (IE) 2002-11-21 — — US disclosed
US-6478989-B1 Aromatic substituted naphthopyrans TRANSITIONS OPTICAL, INC. 2002-11-12 — — US disclosed
EP-1000025-A4 SUBSTITUTED NAPHTHOPYRANS TRANSITIONS OPTICAL INC (US) 2002-10-09 — — EP disclosed
EP-1000025-A1 SUBSTITUTED NAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 2000-05-17 — — EP disclosed
US-5961892-A PHOTOCHROMIC PPG INDUSTRIES OHIO, INC. (US) 1999-10-05 — — US disclosed
WO-1998055457-A1 SUBSTITUTED NAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 1998-12-10 — — WO disclosed
EP-0835870-A1 Photochromic substituted naphthopyrans PPG INDUSTRIES, INC. (US) 1998-04-15 — — EP disclosed
WO-1998014443-A1 NOVEL SUBSTITUTED NAPHTHOPYRANS PPG INDUSTRIES, INC. (US) 1998-04-09 — — WO disclosed
US-5658500-A REVERSIBLE PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 1997-08-19 — — US disclosed
US-5656206-A OPHTHALIMIC LENSES; RADIATION TRANSPARENT; PHOTOCHROMISM TRANSITIONS OPTICAL, INC. (US) 1997-08-12 — — US disclosed
US-5650098-A PHOTOCHROMIC LENSES TRANSITIONS OPTICAL, INC. (US) 1997-07-22 — — US disclosed
US-5573712-A PHOTOCHROMIC ARTICLE COMPRISING ORGANIC HOST AND THE PHOTOCHROMIC NAPHTHOPYRAN TRANSITIONS OPTICAL, INC. (US) 1996-11-12 — — US disclosed
US-5458814-A Ophthalmic lenses TRANSITIONS OPTICAL, INC. (US) 1995-10-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173667-A1 NOVEL AROMATIC SUBSTITUTED NAPHTHOPYRANS TYR, B3GNT2, PAH PDE10A 4050/4885LDHA 4082/4885LDHB 4381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback